Bestewil Holding Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
Bestewil Holding General Information
Description
Producer of vaccines. The company engages in the development of a proprietary vaccine delivery platform (virosome) as well as intranasal influenza and RSV vaccines.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- Ant. Deusinglaan 1
- 9713 AV Groningen
- Netherlands
Bestewil Holding Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bestewil Holding Patents
Bestewil Holding Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2014406150-A1 | Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby | Active | 12-Sep-2014 | 000000000 | |
| AU-2014406150-B2 | Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby | Active | 12-Sep-2014 | 000000000 | |
| CA-2960948-C | Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby | Active | 12-Sep-2014 | 000000000 | |
| EP-3191123-B1 | Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby | Active | 12-Sep-2014 | 000000000 | |
| US-20170189523-A1 | Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby | Active | 12-Sep-2014 | A61K39/12 |
Bestewil Holding Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Antonius Stegmann | Founder and Chief Scientific Officer |
Bestewil Holding Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|